Study guide

31.5 Oral Potentially Malignant Disorders

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

31.5 Oral Potentially Malignant Disorders

Key Takeaways Explain This Topic AI

Leukoplakia is a clinical diagnosis of exclusion: a white patch of questionable risk once other known disorders are excluded.

Homogeneous leukoplakia transforms in roughly 1% to 5% of cases, while non-homogeneous forms transform in 15% to 30% or more.

Erythroplakia is the single most dangerous oral potentially malignant disorder, with a very high rate of dysplasia or carcinoma at first biopsy.

The floor of the mouth, ventrolateral tongue and retromolar and soft palate complex are the highest-risk sites.

Oral submucous fibrosis is caused by areca nut and presents with blanching, fibrous bands and progressive trismus.

Last updated: September 2026

World Health Organization (WHO) Classification of OPMDs

The World Health Organization defines an Oral Potentially Malignant Disorder (OPMD) as "any mucosal abnormality that carries an increased risk of developing oral squamous cell carcinoma (OSCC), either in the site of the lesion or elsewhere in the oral cavity." It replaces older terms such as "precancer" or "premalignant lesion", recognizing that generalized field cancerization may affect the entire upper aerodigestive tract. Oral Potentially Malignant Disorders (OPMDs)

  • │
  • ┌──────────────────┬─────────────────────┼─────────────────────┬──────────────────┐
  • ▼ ▼ ▼ ▼ ▼
  • Leukoplakia Erythroplakia Oral Lichen Planus Oral Submucous Actinic Cheilitis
  • White patch • Red velvety patch • T-cell autoimmune • Areca nut / Betel • Chronic UV-B
  • By exclusion • >85-90% severe • Wickham's striae • Fibrous banding • Lower lip border
  • Homogeneous vs dysplasia / OSCC • Civatte bodies • Trismus • Outdoor workers
  • Non-homogeneous • Highest risk • ~1% malignancy risk • 7-10% malignancy • 5-10% malignancy
  • 1. Oral Leukoplakia

Definition (WHO): "A predominantly white plaque of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer." Leukoplakia is strictly a clinical diagnosis of exclusion . Before designating a white lesion as leukoplakia, the clinician must exclude identifiable conditions such as frictional keratosis, cheek-biting keratosis, candidiasis, lichen planus, chemical burns, leucoedema, and white sponge nevus.

Clinical Subtypes:

Homogeneous Leukoplakia: Uniform, flat, thin, smooth, wrinkled, or finely cracked ("cracked mud") white patch with clear margins. Low risk of malignant transformation ( 1% to 5% ).

Non-Homogeneous Leukoplakia: Carries an substantially higher malignant transformation potential ( 15% to 30%+ ). Subdivided into:

Speckled Leukoplakia (Erythroleukoplakia): Mixed red and white lesion where white keratotic patches are interspersed with erythematous atrophic patches. Carries the highest risk of malignant progression among leukoplakias.

Nodular Leukoplakia: White surface composed of irregular rounded excrescences, nodules, or pebbles.

Verrucous Leukoplakia: Exophytic, heavily keratinised, warty, or corrugated surface.

Proliferative Verrucous Leukoplakia (PVL): A distinct, aggressive, non-smoking-related form of OPMD, predominantly affecting elderly females. It begins as flat homogeneous hyperkeratosis that insidiously spreads across multiple oral sites, transforming into diffuse verrucous plaques with an exceptionally high rate of malignant transformation ( >60–70% ) into verrucous carcinoma or OSCC, refractory to surgery.

High-Risk Anatomical Sites: In the UK, leukoplakias located in the floor of the mouth , ventrolateral tongue , and retromolar complex / soft palate exhibit the highest propensity for harboring severe dysplasia or invasive carcinoma. Sublingual keratosis (diffuse white patch on the anterior floor of the mouth resembling an "eburnated butterfly") carries an exceptionally grave prognosis.

2. Oral Erythroplakia

Definition (WHO): "A predominantly red patch of the oral mucosa that cannot be characterized clinically or pathologically as any other identifiable red condition." Specific conditions to exclude include erythematous candidiasis, denture stomatitis, vascular malformations, trauma, and desquamative gingivitis.

Clinical Appearance: A smooth, fiery red, velvety, granular, or slightly depressed plaque with distinct, sharply demarcated margins. Often asymptomatic, though patients may notice mild burning.

Malignant Transformation Risk: Erythroplakia is the single most dangerous OPMD . Histopathologically, >85% to 90% of all true erythroplakias demonstrate severe epithelial dysplasia, carcinoma-in-situ, or frank invasive OSCC at the time of the initial diagnostic biopsy. Any unexplained persistent solitary red lesion MUST be treated with immediate suspicion and biopsied without delay.

3. Oral Lichen Planus (OLP)

Etiopathogenesis: A chronic, immune-mediated mucocutaneous inflammatory disorder mediated by CD8+ cytotoxic T-lymphocytes . Antigenic alteration of basal keratinocytes induces T-cells to release perforin, granzymes, TNF-α, and interferon-gamma (IFN-γ), driving programmed cell death ( apoptosis ) of the basal cell layer and matrix metalloproteinase-mediated destruction of the basement membrane.

Clinical Types of OLP:

Reticular Type: The most common and pathognomonic variant. Presents as asymptomatic, bilateral, symmetrical networks of raised, interlacing fine white keratotic lines known as Wickham's striae , most prominent on the posterior buccal mucosa, lateral tongue, and gingiva.

Papular Type: Small, pinpoint, white papules (0.5–1 mm), often accompanying reticular striae.

Plaque-like Type: Smooth or rough, homogeneous white patches resembling leukoplakia, predominantly on the dorsum of the tongue; common in smokers.

Atrophic (Erythematous) Type: Smooth, red, thinned, raw mucosal areas often flanked by peripheral Wickham's striae. When affecting attached gingiva, it causes desquamative gingivitis (fiery red, glazed gingiva that strips away with gentle air or friction).

Erosive / Ulcerative Type: Highly painful, irregular, extensive shallow ulcers covered by a yellowish-fibrinous exudate and surrounded by radiating striae. Exacerbated by acidic, hot, or spicy foods.

Bullous Type: Rare variant characterized by short-lived fluid-filled vesicles that rupture rapidly, leaving raw erosions. Histological Hallmarks of OLP

  • │
  • ┌──────────────────┬──────────────────────┴──────────────────────┬──────────────────┐
  • ▼ ▼ ▼ ▼
  • Hyperkeratosis Liquefactive Civatte Bodies Band-like T-cell
  • & "Saw-Tooth" Degeneration • Apoptotic, necrotic Infiltrate
  • Rete Pegs • Basal cell vacuolation basal keratinocytes • Dense, ribbon-like
  • Parakeratosis or and hydropic change • Eosinophilic hyaline • Confined strictly to
  • orthokeratosis • Loss of basement globules in papillary subepithelial lamina
  • Pointed rete pegs membrane integrity dermis / lower strata propria

Histological Diagnostic Criteria of OLP:

Hyperparakeratosis or hyperorthokeratosis with a characteristic "saw-tooth" pointed morphology of the epithelial rete ridges.

Liquefactive (hydropic) degeneration of the basal cell layer , where basal keratinocytes become vacuolated, lose hemidesmosomal attachments, and rupture.

Civatte (colloid / cytoid) bodies: Apoptotic, rounded, anucleate, eosinophilic hyaline structures found in the lower epithelial strata and papillary lamina propria, representing dead necrotic keratinocytes.

A dense, well-demarcated, band-like (ribbon-like) infiltrate of mature T-lymphocytes confined strictly to the superficial subepithelial lamina propria, directly abutting the basement membrane.

Absence of epithelial dysplasia (the presence of cellular atypia indicates lichenoid dysplasia or OSCC).

Oral Lichenoid Reactions (OLRs): Lesions that clinically and histologically mimic OLP but possess an identifiable extrinsic trigger:

Oral Lichenoid Drug Reactions (OLDR): Triggered by systemic drugs including ACE inhibitors (captopril, enalapril), beta-blockers, NSAIDs, sulfonylureas, antimalarials, and thiazide diuretics. Characteristically unilateral, more erosive, and resolve upon physician-guided drug substitution.

Contact Lichenoid Reactions: Caused by delayed Type IV contact hypersensitivity to corrosion products (mercury salts) leaking from adjacent dental amalgam restorations . Strictly confined to the mucosal surface in direct physical contact with the restoration; resolves within 3–6 months following replacement of the amalgam with composite or ceramic.

Malignant Transformation of OLP: Estimated at approximately 1% over the patient's lifetime. Risk is significantly elevated in the atrophic and erosive/ulcerative variants. Patients with OLP require lifelong annual or biannual surveillance in secondary care or specialized dental clinics.

4. Oral Submucous Fibrosis (OSMF)

Etiology: A chronic, insidious, progressive fibrotic condition strongly associated with the habitual chewing of areca nut (betel nut, supari) , betel quid (pan), or commercial formulations ( gutkha, pan masala ). Areca nut alkaloids, primarily arecoline , stimulate oral fibroblasts to upregulate collagen production and cross-linking, while inhibiting the activity of collagenase via tissue inhibitor of metalloproteinases-1 (TIMP-1). Flavanoids and copper ions within areca nut further upregulate lysyl oxidase, rendering collagen resistant to degradation.

Clinical Presentation:

Early stage: Mucosal burning sensation (stomatopyrosis) provoked by spicy foods, vesicle formation, petechiae, and excessive salivation.

Fibrotic stage: Progressive loss of mucosal elasticity, diffuse blanching (pale, leathery, marble-like porcelain mucosa), and loss of lingual papillae. Palpation reveals dense, vertical, fibrous bands running through the buccal mucosa, soft palate, and labial mucosa.

Advanced stage: Severe, progressive restriction of mouth opening ( trismus ), loss of uvular mobility ("bud-shaped" shrunken uvula), sunken cheeks, and difficulty with speech, mastication, and swallowing.

Malignant Transformation Risk: OSMF carries a high transformation rate of 7% to 10% . The dense fibrosis is irreversible; cessation of betel quid halts further progression but does not restore tissue elasticity. Surgical release of bands often results in contracture and recurrence.

5. Actinic Cheilitis (Farmer's Lip / Sailor's Lip)

Caused by cumulative exposure to ultraviolet radiation ( UV-B ), predominantly affecting the vermilion border of the lower lip in fair-skinned individuals who work outdoors.

Features: Loss of the sharp vermilion-cutaneous border, pale dry scaly patches, focal leukoplakia, and persistent linear fissures. Carries a 5% to 10% transformation rate to invasive squamous cell carcinoma of the lip.

  • Condition Major Etiological Factor Typical Clinical Morphology Lifetime Malignant Transformation Risk
  • Homogeneous Leukoplakia Tobacco, idiopathic Uniform, flat, smooth or cracked white plaque Low (1–5%)

Non-Homogeneous Leukoplakia Tobacco, alcohol, candida Speckled (erythroleukoplakia), nodular, or verrucous High (15–30%+)

Erythroplakia Tobacco, heavy alcohol Bright red, velvety, sharply demarcated plaque Extreme (>85–90% severe dysplasia/OSCC)

Oral Lichen Planus Autoimmune CD8+ T-cells Reticular Wickham's striae, erosions, desquamative gingivitis Low (~1%)

Oral Submucous Fibrosis Areca nut (gutkha, pan) Mucosal blanching, dense fibrous bands, severe trismus High (7–10%)

Actinic Cheilitis Solar UV-B radiation Scaly, atrophic, leukoplakic lower lip with loss of border Moderate (5–10%)

Sections you finish are checked off in the contents.

  • Up Next
  • 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy
  • Continue learning